| __timestamp | Ligand Pharmaceuticals Incorporated | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 55402000 | 11503000 |
| Thursday, January 1, 2015 | 66107000 | 24698000 |
| Friday, January 1, 2016 | 103402000 | 26076000 |
| Sunday, January 1, 2017 | 135736000 | 33570000 |
| Monday, January 1, 2018 | 245116000 | 58697000 |
| Tuesday, January 1, 2019 | 108935000 | 80279000 |
| Wednesday, January 1, 2020 | 156000000 | 84228000 |
| Friday, January 1, 2021 | 214957000 | 106025000 |
| Saturday, January 1, 2022 | 143418000 | 109788000 |
| Sunday, January 1, 2023 | 96265000 | 135576000 |
Infusing magic into the data realm
In the ever-evolving landscape of biotechnology, Vericel Corporation and Ligand Pharmaceuticals Incorporated have showcased intriguing financial trajectories over the past decade. From 2014 to 2023, Ligand Pharmaceuticals experienced a notable fluctuation in gross profit, peaking in 2018 with a remarkable 245% increase from its 2014 figures. However, by 2023, Ligand's gross profit had decreased by approximately 61% from its 2018 high.
Conversely, Vericel Corporation demonstrated a consistent upward trend, with its gross profit growing by nearly 1,080% from 2014 to 2023. This steady growth highlights Vericel's robust market strategy and operational efficiency. The year 2023 marked a significant milestone for Vericel, as it surpassed Ligand in gross profit for the first time in this period.
These trends underscore the dynamic nature of the biotech industry, where strategic innovation and market adaptation are key to financial success.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Ligand Pharmaceuticals Incorporated
Who Generates Higher Gross Profit? Vertex Pharmaceuticals Incorporated or Vericel Corporation
Takeda Pharmaceutical Company Limited and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Biogen Inc. or Ligand Pharmaceuticals Incorporated
Gross Profit Analysis: Comparing Dr. Reddy's Laboratories Limited and Vericel Corporation
Key Insights on Gross Profit: Catalent, Inc. vs Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Ascendis Pharma A/S vs Vericel Corporation
Cost of Revenue Trends: Vericel Corporation vs Ligand Pharmaceuticals Incorporated
R&D Spending Showdown: Vericel Corporation vs Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Vericel Corporation vs Amphastar Pharmaceuticals, Inc.
Gross Profit Comparison: Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Trends